Literature DB >> 11576221

Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus.

S Ghosh1, J Walker, D C Jackson.   

Abstract

The fusion protein of canine distemper virus (CDV-F), a 662 amino-acid envelope protein, was used as the target molecule for identification of canine T helper (Th) epitopes. A library of 94 peptides, each 17 residues in length overlapping by 10 residues and covering the entire sequence of CDV-F, was screened using a lymphocyte proliferation assay with peripheral blood mononuclear cells (PBMC) obtained from dogs inoculated with canine distemper virus (CDV) vaccine. Initially we observed low and inconsistent proliferation of PBMC in response to these peptides, even when using cells obtained from dogs that had received multiple doses of CDV. Subsequently, the use of expanded cell populations derived by in vitro stimulation of canine PBMC with pools of peptides allowed the identification of a number of putative canine Th-epitopes within the protein sequence of CDV-F. There were two major clusters of Th-epitopes identified close to the cleavage site of the F0 fusion protein, while some others were scattered in both the F1 and F2 fragments of the protein. Some of these peptides, in particular peptide 35 (p35), were stimulatory in dogs of different breeds and ages. The identification of such promiscuous canine Th-epitopes encouraged us to assemble p35 in tandem with luteinising hormone releasing hormone (LHRH) a 10 amino-acid residue synthetic peptide representing a B-cell epitope which alone induces no antibody in dogs. The totally synthetic immunogen was able to induce the production of very high titres of antibodies against LHRH in all dogs tested. These results indicate that p35 could be an ideal candidate for use as a Th-epitope for use in outbred dogs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576221      PMCID: PMC1783274          DOI: 10.1046/j.0019-2805.2001.01271.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.

Authors:  A S Mustafa; F A Shaban; A T Abal; R Al-Attiyah; H G Wiker; K E Lundin; F Oftung; K Huygen
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  The nucleotide sequence of the gene encoding the F protein of canine distemper virus: a comparison of the deduced amino acid sequence with other paramyxoviruses.

Authors:  T Barrett; D K Clarke; S A Evans; B K Rima
Journal:  Virus Res       Date:  1987-11       Impact factor: 3.303

3.  Carrier-priming leads to hapten-specific suppression.

Authors:  L A Herzenberg; T Tokuhisa; L A Herzenberg
Journal:  Nature       Date:  1980-06-26       Impact factor: 49.962

4.  Measles virus polypeptides synthesis in infected cells.

Authors:  M C Graves; S M Silver; P W Choppin
Journal:  Virology       Date:  1978-05-01       Impact factor: 3.616

5.  Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans.

Authors:  C D Partidos; M W Steward
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

6.  Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.

Authors:  M E Levely; C A Bannow; C W Smith; J A Nicholas
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  Delineation of canine parvovirus T cell epitopes with peripheral blood mononuclear cells and T cell clones from immunized dogs.

Authors:  G F Rimmelzwaan; M C Poelen; R H Meloen; J Carlson; F G UytdeHaag; A D Osterhaus
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

8.  Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.

Authors:  M P Schutze; C Leclerc; M Jolivet; F Audibert; L Chedid
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Protection against canine distemper virus in dogs after immunization with isolated fusion protein.

Authors:  E Norrby; G Utter; C Orvell; M J Appel
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

10.  Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H Su; R P Morrison; N G Watkins; H D Caldwell
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  8 in total

1.  A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.

Authors:  David C Jackson; Yuk Fai Lau; Thuy Le; Andreas Suhrbier; Georgia Deliyannis; Christina Cheers; Corey Smith; Weiguang Zeng; Lorena E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

Review 2.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building.

Authors:  Weiguang Zeng; Kylie J Horrocks; Gorjana Robevska; Chinn Yi Wong; Kristy Azzopardi; Marija Tauschek; Roy M Robins-Browne; David C Jackson
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

4.  A comparison of the immune responses of dogs exposed to canine distemper virus (CDV) - Differences between vaccinated and wild-type virus exposed dogs.

Authors:  Danielle Perrone; Scott Bender; Stefan Niewiesk
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

5.  A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.

Authors:  Brendon Y Chua; Emily M Eriksson; Lorena E Brown; Weiguang Zeng; Eric J Gowans; Joseph Torresi; David C Jackson
Journal:  Vaccine       Date:  2008-04-07       Impact factor: 3.641

6.  Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

Authors:  Hannah H Alphs; Ratish Gambhira; Balasubramanyam Karanam; Jeffrey N Roberts; Subhashini Jagu; John T Schiller; Weiguang Zeng; David C Jackson; Richard B S Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

7.  Human Paramyxovirus Infections Induce T Cells That Cross-React with Zoonotic Henipaviruses.

Authors:  Rory D de Vries; Alwin de Jong; R Joyce Verburgh; Lucie Sauerhering; Gijsbert P van Nierop; Robert S van Binnendijk; Albert D M E Osterhaus; Andrea Maisner; Marion P G Koopmans; Rik L de Swart
Journal:  mBio       Date:  2020-07-07       Impact factor: 7.867

8.  Construction of an expression system for bioactive IL-18 and generation of recombinant canine distemper virus expressing IL-18.

Authors:  Yuxiu Liu; Hiroki Sato; Masahiro Hamana; Navita Anisia Moonan; Misako Yoneda; Xianzhu Xia; Chieko Kai
Journal:  J Vet Med Sci       Date:  2014-06-04       Impact factor: 1.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.